Results 41 to 50 of about 342 (178)
Mastocitosis asociada a trombocitemia esencial
Actas Dermo-Sifiliográficas, 2019 J. Marcoval
core +2 more sources
Mastocitosis cutánea difusa en pediatría, una entidad de difícil diagnostico
, 2022 Objective: To present the possibilities of cutaneous mastocytosis in pediatrics. Case presentation: We present the case of a male infant with pemphigoid symptoms who underwent multiple studies suggested by a multidisciplinary team, finally the diagnosis ...
Sanchez Quintero , Karen Lorena +6 more
core +1 more source
Mastocitoma solitario. Comunicación de un caso
Revista Alergia México, 2023 Antecedentes: El mastocitoma solitario es una variante de mastocitosis cutánea de buen pronóstico, congénita, que aparece durante las primeras semanas de vida.
Camila Delgadillo Jordán
doaj +1 more source
Mastocitosis sistémica: Revisión sistemática [PDF]
Anales de Medicina Interna, 2008 La mastocitosis es una enfermedad definida por un crecimiento anormal y por la acumulación de mastocitos. En la clasificación de consenso de la OMS del 2001, se distinguió entre procesos bien limitados a piel (mastocitosis cutánea) o bien acumulados a nivel de otros tejidos: médula ósea y/u otros órganos extracutáneos (mastocitosis sistémica) como ...
Molina-Garrido, M.J. +6 more
openaire +3 more sources
HemaSphere, Volume 3, Issue S1, Page 889-890, June 2019., 2019 Background: Hearing loss and blindness are seldom encountered as primary manifestations in patients with chronic myeloid leukemia. Chronic myeloid leukemia (CML) commonly presents with weakness, dysphagia, abdominal distension and pain and rarely constitutional symptoms.
S., S. Tandon, R. Gupta, S. Nityanand
wiley +1 more source
Mastocitosis cutánea pediátrica. Estudio en el área de salud Alicante-Hospital General Universitario Dr. Balmis en el período 2002-2022. [PDF]
, 2023 Introducción: Las mastocitosis cutáneas son patologías de baja frecuencia poblacional. En la mayoría de los pacientes pediátricos presentan buen pronóstico asociado a remisión espontánea de la enfermedad antes de la pubertad.
Pedruelo Iglesias, Marina
core
HemaSphere, Volume 3, Issue S1, Page 890, June 2019., 2019 Background: Myelodysplastic syndrome (MDS) is a heterogeneous group of diseases characterized by ineffective erythropoiesis and dysplasia. MDS and its subtype CMML is highly associated with chronic inflammatory and autoimmune diseases; however the combination of MDS with other bone marrow neoplasms is not a common entity. Only few cases of MDS combined
A. Sevoyan, A. Sevoyan
wiley +1 more source
HemaSphere, Volume 3, Issue S1, Page 890-891, June 2019., 2019 Background: We present here the case of a 52 year old male patient who was diagnosed of D816 V + indolent systemic mastocytosis in 2006. The patient received only symptomatic treatment with fexofenadine, sodium cromoglycate, and ranitidine. In November 7th 2016, mild leukocytosis was detected in one of the screenings.
A. Savchuk +8 more
wiley +1 more source
PB2227 COMPASSIONATE USE OF ROPEGINTERFERON TO TREAT MYELOPROLIFERATIVE NEOPLASMS IN TAIWAN
HemaSphere, Volume 3, Issue S1, Page 999, June 2019., 2019 Background: There is a high unmet medical need for therapeutic options for patients suffering from myeloproliferative neoplasms (MPN), who have failed or are not eligible to available treatment options. Ropeginterferon‐alfa‐2b (P1101) is a novel, third generation pegylated interferon‐alfa, recently approved by EMA to treat polycythemia vera (PV ...
C.‐C. Chen +7 more
wiley +1 more source